Differential Effect of Wall Tension on Matrix Metalloproteinase Promoter Activation in the Thoracic Aorta

Journal of Surgical Research

Volumn 160, Issue 2, 2010, Pages 333-339

  Ruddy, Jean Marie ^a   Jones, Jeffrey A ^a   Stroud, Robert E ^a   Mukherjee, Rupak ^a   Spinale, Francis G ^a   Ikonomidis, John S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

matrix metalloproteinase; thoracic aorta; vascular remodeling; wall tension

Indexed keywords

BETA GALACTOSIDASE; GELATINASE A; GELATINASE B;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE FUSION; GENE INSERTION; GENE SEQUENCE; GENOME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; THORACIC AORTA; TRANSGENIC MOUSE; VASCULAR RING;

ANIMALS; AORTA, THORACIC; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; LAC OPERON; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; RABBITS; RATS; RNA, MESSENGER; STRESS, MECHANICAL; VASOCONSTRICTION;

EID: 77950916273     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.12.033     Document Type: Article

References (36)

1. Raffetto J.D., and Khalil R.A. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 75 (2008) 346
2. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 90 (2002) 251
3. Barbour J.R., Spinale F.G., and Ikonomidis J.S. Proteinase systems and thoracic aortic aneurysm progression. J Surg Res 139 (2007) 292
4. Aimes R.T., and Quigley J.P. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem. 270 (1995) 5872
5. Lehoux S., and Tedgui A. Signal transduction of mechanical stresses in the vascular wall. Hypertension 32 (1998) 338
6. Korshunov V.A., Schwartz S.M., and Berk B.C. Vascular remodeling: Hemodynamic and biochemical mechanisms underlying Glagov's phenomenon. Arterioscler Thromb Vasc Biol 27 (2007) 1722
7. Hall A.J., Busse E.F., McCarville D.J., et al. Aortic wall tension as a predictive factor for abdominal aortic aneurysm rupture: Improving the selection of patients for abdominal aortic aneurysm repair. Ann Vasc Surg 14 (2000) 152
8. Mukherjee R., Mingoia J.T., Bruce J.A., et al. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction. Am J Physiol Heart Circ Physiol 291 (2006) H2216
9. Mohan R., Rinehart W.B., Bargagna-Mohan P., et al. Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling. J Biol Chem 273 (1998) 25903
10. Bond B.R., Zellner J.L., Dorman B.H., et al. Differential effects of calcium channel antagonists in the amelioration of radial artery vasospasm. Ann Thorac Surg 69 (2000) 1035 discussion 1040
11. Swafford Jr. A.N., Harrison-Bernard L.M., and Dick G.M. Knockout mice reveal that the angiotensin II type 1B receptor links to smooth muscle contraction. Am J Hypertens 20 (2007) 335
12. He G.W., Angus J.A., and Rosenfeldt F.L. Reactivity of the canine isolated internal mammary artery, saphenous vein, and coronary artery to constrictor and dilator substances: Relevance to coronary bypass graft surgery. J Cardiovasc Pharmacol 12 (1988) 12
13. Lalli J., Harrer J.M., Luo W., et al. Targeted ablation of the phospholamban gene is associated with a marked decrease in sensitivity in aortic smooth muscle. Circ Res 80 (1997) 506
14. Mott J.D., and Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16 (2004) 558
15. Davis V.A., Persidskaia R.N., Baca-Regen L.M., et al. Cytokine pattern in aneurysmal and occlusive disease of the aorta. J Surg Res 101 (2001) 152
16. Shimizu K., Shichiri M., Libby P., et al. Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. J Clin Invest 114 (2004) 300
17. Grote K., Flach I., Luchtefeld M., et al. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 92 (2003) e80
18. Tronc F., Mallat Z., Lehoux S., et al. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: Interaction with NO. Arterioscler Thromb Vasc Biol 20 (2000) E120
19. Anstadt M.P., Franga D.L., Portik-Dobos V., et al. Native matrix metalloproteinase characteristics may influence early stenosis of venous versus arterial coronary artery bypass grafting conduits. Chest 125 (2004) 1853
20. Coady M.A., Rizzo J.A., Goldstein L.J., et al. Natural history, pathogenesis, and etiology of thoracic aortic aneurysms and dissections. Cardiol Clin 17 (1999) 615
21. von Offenberg Sweeney N., Cummins P.M., Birney Y.A., et al. Cyclic strain-mediated regulation of endothelial matrix metalloproteinase-2 expression and activity. Cardiovasc Res 63 (2004) 625
22. Brandes R.P., Kim D., Schmitz-Winnenthal F.H., et al. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: Role of soluble guanylyl cyclase. Hypertension 35 (2000) 231
23. Sutliff R.L., Hoying J.B., Kadambi V.J., et al. Phospholamban is present in endothelial cells and modulates endothelium-dependent relaxation. Evidence from phospholamban gene-ablated mice. Circ Res 84 (1999) 360
24. Sutliff R.L., Weber C.S., Qian J., et al. Vasorelaxant properties of parathyroid hormone-related protein in the mouse: Evidence for endothelium involvement independent of nitric oxide formation. Endocrinology 140 (1999) 2077
25. Flamant M., Placier S., Dubroca C., et al. Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension 50 (2007) 212
26. Hoit B.D., Kiatchoosakun S., Restivo J., et al. Naturally occurring variation in cardiovascular traits among inbred mouse strains. Genomics 79 (2002) 679
27. Lehoux S., Lemarie C.A., Esposito B., et al. Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation 109 (2004) 1041
28. Deschamps A.M., and Spinale F.G. Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation. Cardiovasc Res 69 (2006) 666
29. Ikonomidis J.S., Jones J.A., Barbour J.R., et al. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves. J Thorac Cardiovasc Surg 133 (2007) 1028
30. Schmoker J.D., McPartland K.J., Fellinger E.K., et al. Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms. J Thorac Cardiovasc Surg 133 (2007) 155
31. Tamarina N.A., McMillan W.D., Shively V.P., et al. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 122 (1997) 264 discussion 271
32. Sharony R., Pintucci G., Saunders P.C., et al. Matrix metalloproteinase expression in vein grafts: Role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2. Am J Physiol Heart Circ Physiol 290 (2006) H1651
33. Ahmed S.H., Clark L.L., Pennington W.R., et al. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 113 (2006) 2089
34. Alla F., Kearney-Schwartz A., Radauceanu A., et al. Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes. Eur J Heart Fail 8 (2006) 147
35. Tan J., Hua Q., Xing X., et al. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension. Hypertens Res 30 (2007) 959
36. Yasmin, McEniery C.M., Wallace S., et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 25 (2005) 372